LONDON, Oct 27 (Reuters) - Surging vigor costs successful Europe hazard accelerating the exodus of companies captious to the manufacture of indispensable medicines, further endangering cause proviso chains deed by shortages astatine the tallness of COVID-19, pharmaceutical steadfast Teva said successful a study connected Thursday.
Essential medicines are important to treating semipermanent conditions arsenic good arsenic being cardinal to surgical procedures. They are besides typically off-patent, sold astatine the lowest imaginable prices acceptable by nationalist wellness agencies oregon insurers' associations successful European subordinate states.
This unit connected pricing for these cardinal generic medicines has agelong pushed manufacturing of the most-energy intensive constituent - progressive pharmaceutical ingredients - eastwards to India and China, wherever costs are dramatically lower.
Now, the warfare successful Ukraine and the associated vigor and economical situation threatens to "debase the continent's pharmaceutical assemblage for bully for immoderate captious medicines," Teva (TEVA.TA) wrote successful its report.
Reporting by Natalie Grover successful London; Editing by William Maclean
Our Standards: The Thomson Reuters Trust Principles.
English (US)